Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2020 September Corona Helsinki airport deploys sniffer dogs as fast and reliable corona testers Read more
2020 September Pharma News Novel CML-treatment asciminib performs as hoped in phase III trial Read more
2020 September Viewpoints AI-driven healthcare solutions adopted faster in low- and middle-income countries Read more
2020 August Pharma News Novel treatment for sickle cell disease granted Orphan Drug designation in EU Read more
2020 August Corona Students at Liège university bring in weekly saliva sample for corona testing Read more
Top
